Company Filing History:
7 out of 1,036 
1 out of 12 Years Active: 1998-2009
Title: Yihai Cao: Innovator in Angiogenesis Research
Introduction
Yihai Cao is a prominent inventor based in Stockholm, Sweden, known for his significant contributions to the field of angiogenesis research. With a total of eight patents to his name, he has made remarkable strides in understanding and treating angiogenesis-related diseases, particularly cancer.
Latest Patents
Cao's latest patents include groundbreaking work on nucleic acids encoding plasminogen fragments and methods of use. One notable patent focuses on a nucleic acid sequence encoding the kringle region fragment of plasminogen, which is essential for gene therapy and recombinant expression aimed at treating angiogenesis-dependent diseases. Another significant invention is the angiostatin protein, which comprises plasminogen fragments containing kringle region domains that exhibit anti-angiogenic activity. This innovation holds promise for the treatment of various angiogenesis-dependent diseases, including cancer.
Career Highlights
Throughout his career, Yihai Cao has worked with esteemed organizations such as Children's Medical Center Corporation and Karolinska Innovations AB. His work has been pivotal in advancing the understanding of angiogenesis and its implications for cancer treatment.
Collaborations
Cao has collaborated with notable figures in the field, including M Judah Folkman and Michael S O'Reilly. These partnerships have further enriched his research and contributed to the development of innovative therapeutic strategies.
Conclusion
Yihai Cao's contributions to angiogenesis research and his innovative patents underscore his role as a leading inventor in the medical field. His work continues to pave the way for new treatments for cancer and other related diseases.